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Abstract
Simple and efficient synthesis of quebecol and a number of its analogs was accomplished in five
steps. The synthesized compounds were evaluated for antiproliferative activities against human
cervix adenocarcinoma (HeLa), human ovarian carcinoma (SKOV-3), human colon carcinoma
(HT-29), and human breast adenocarcinoma (MCF-7) cancer cell lines. Among all the compounds,
7c, 7d, 7f, and 8f exhibited antiproliferative activities against four tested cell lines with inhibition
over 80% at 75 μM after 72 h, whereas, compound 7b and 7g were more selective towards MCF-7
cell line. The IC50 values for compounds 7c, 7d, and 7f were 85.1 μM, 78.7 μM, and 80.6 μM
against MCF-7 cell line, respectively, showing slightly higher antiproliferactive activtiy than the
synthesized and isolated quebecol with an IC50 value of 104.2 μM against MCF-7.
Maple syrup is obtained by thermal evaporation of sap collected from certain maple (Acer)
species including the sugar maple (A. saccharum) tree, and contains a mixture of native
phenolics and compounds formed during the intensive heating process required to transform
maple sap into syrup.1 Quebecol [2,3,3-tri-(3-methoxy-4-hyroxyphenyl)-1-propanol] (Figure
1) was isolated by us from a butanol extract of Canadian maple syrup,2,3 and it was named
after the province of Quebec in Canada the world’s largest producer of maple syrup.
Quebecol is a process-derived polyphenolic compound with a unique chemical structure that
has never before been identified in nature nor is it present in sap.
Quebecol displays some similarity to the known drug, tamoxifen that is a widely used
chemotherapy agent for hormonally dependent cancers such as breast cancer. However,
tamoxifen has severe side effects. Quebecol is a phytochemical derived compound present in
maple syrup, which has been consumed for centuries without showing toxicity. Thus, based
on structural similarities to tamoxifen and in vitro biological assays4 on breast and colon
cancer cell lines in our laboratory, we hypothesized that quebecol and analogs could exert
© 2013 Elsevier Ltd
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greater anticancer effects than tamoxifen without the adverse side effects. Moreover, it has
been reported that maple syrup extracts have antioxidant, antimutagenic, and human cancer
cell antiproliferative properties.5
Unfortunately, sufficient quantity of the pure quebecol could not be isolated to conduct
detailed biological evaluation. Thus, we focused our attention towards the synthesis of
quebecol and its analogs to evaluate their biological activities.6 Herein, we report total
synthesis of quebecol and its derivatives as mixed isomers and evaluation of their
antiproliferative activities against a panel of cancer cell lines.
Synthesis of quebecol and its analogs was accomplished as depicted in Scheme 1. The key
starting materials, substituted bromobenzenes (1a-d) as well as benzaldehydes (2a-d) were
synthesized by benzylation of commercially available phenolic compounds with benzyl
bromide in the presence of potassium carbonate in acetone. The synthesis of quebecol (8a)
commenced with Grignard reaction of 1-(benzyloxy)-4-bromo-2-methoxybenzene (1a) and
4-(benzyloxy)-3-methoxybenzaldehyde (2a) to give (bis(4-(benzyloxy)-3-
methoxyphenyl)methanol (3a) in 46% yield. Similarly, lithiation of bromo compound 1a
using n-BuLi at -78 °C followed by the addition of aldehyde (2a) offered good yields of 3a
(45-62%) along with minor impurity, 1-(4-(benzyloxy)-3-methoxy phenyl)pentan-1-ol,
produced by direct substitution of butyl ion on benzaldehyde. Although, Grignard reaction
furnished reasonable yield of 3a, n-BuLi reaction was preferred because of the concern over
reproducibility of Grignard results.
The reaction of biphenyl alcohol 3a with ethyl 2-(4-(benzyloxy)-3-methoxyphenyl)acetate
(5a') in the presence of a catalytic amount of p-toluenesulphonic acid in benzene and 1,2-
dichloroethane to obtain coupling product, ethyl 2,3,3-tris(4-(benzyloxy)-3-
methoxyphenyl)propanoate (6aa') as reported by Harig et al.7 on similar substrates.
Unfortunately, disproportionation products, bis(4-(benzyloxy)-3-methoxyphenyl)methanone
and bis(4-(benzyloxy)-3-methoxyphenyl)methane resulted as major products, which can also
be probable because of electron rich aryl rings in acidic media.8 Witting reaction of bis(4-
(benzyloxy)-3-methoxyphenyl)methanone and (1-(4-(benzyloxy)-3-methoxyphenyl)-2-
ethoxy-2-oxoethyl)triphenylphosphonium bromide failed to give corresponding ethyl 3,3-
bis(4-(benzyloxy)-3-methoxyphenyl)-2-phenylacrylate.
Bromination of diphenyl methanol derivative (3a) to give 4a was considered as an
alternative, which can subsequently react with ester (5a') in the presence of lithium
diisopropylamide (LDA) to give coupled product (6aa'). Several failed attempts were made
for the bromination of alcohol (3a) using brominating agents such as PBr3, POBr3, and
CBr4/PPh3 (Apple reaction). With PBr3, the reaction proceeded smoothly, but isolation was
found to be tricky because of labile nature of bromo compound towards moisture (work up
and purifications trials led to massive decomposition to starting material). Surprisingly,
disproportionation was observed when POBr3 used as brominating agent. No conversion
was observed in case of Apple reaction conditions. Even tosylation, mesylation and
chlorination (using SOCl2)9 of 3a also showed negative results. Finally, acetyl bromide was
found to be effective, and the bromo compound was isolated with excellent yield (80%). By-
product, acetic acid, was removed by simple hexane washings under N2 atmosphere and the
reaction proceeded to the next step without further purification.
LDA was in situ generated from N,N-diisopropylamine and n-BuLi (1.6 M in hexanes) at 0
°C and then treated with ester (5a') at -78 °C. Addition of the bromo compound resulted in
coupled product (6aa') in good yield (52%). The 1H NMR of 6aa′ showed characteristic
peaks at δ 4.38 (d, J = 12.0 Hz, 1H) and 4.09 (d, J = 12.0 Hz, 1H). Presence of peaks at δ
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57.08 and 54.33 in addition to all other carbons of 6aa' in 13C NMR and peak at m/z 756.5
for [M + H2O]+ ion in ESI-MS spectrum confirmed the structure of coupling product 6aa'.
Subsequent reduction of ethyl ester (6) to alcohol (7) was achieved by lithium aluminum
hydride in THF at 0 °C for 2 h with excellent yields (67-87%). The final step for the
synthesis of quebecol and its derivatives involved the removal of benzyl protecting group,
which was effected by reaction of compound 7 with Pd/C and ammonium formate as a
hydrogen source at 25-30 °C for 16 h to provide quebecol and its analogs (9a-g) in excellent
yields (63-88%) as mixed optical isomers. Debenzylation of compound (6) using the same
method afforded compounds 8a-g (Scheme 1). All compounds were characterized by
their 1H and 13C NMR spectra data (Supporting information).
Synthesized quebecol and its derivatives 7aa′-dg′, 8a-g and 9a-f were assessed for their in
vitro antiproliferative activity against a panel of cancer cell lines; human cervix
adenocarcinoma (HeLa), human ovarian carcinoma (SK-OV-3), human colon carcinoma
(HT-29), and human breast adenocarcinoma (MCF-7). The antiproliferative activities of 7aa
′-dg′, 8a-g and 9a-f at 75 μM concentration is shown in terms of percentage cell viability
after 72 h (Figure 2 ).
Ethyl ester derivatives 8c, 8d, 8f, and alcohol derivative 9f inhibited proliferation of four
tested cell lines over 80% at 75 μM after 72 h. Compounds 8b and 8g selectively inhibited
over 75% proliferation of MCF-7 cell lines at 75 μM after 72 h.
Synthesized quebecol 9a was also compared with isolated quebecol and showed a similar
IC50 value of 103.2 μM against MCF-7 after 72 h treatment. Some of the quebecol
derivatives showed slightly higher antiproliferative activity compared to quebecol itself. For
example, the IC50 values for compounds 8c, 8d, and 8f were 85.1 μM, 78.7 μM and 80.6
μM, respectively, against MCF-7 cell line. The quebecol derivatives with protected phenolic
groups on the phenyl ring (6 and 7) were not active against most of the cell lines. Structure-
activity relationship studies indicate that the presence of free phenolic group at para-position
of the phenyl ring is essential for antiproliferative activity and smaller substitutents at meta-
position or no substitient is preferred.
The results showed that quebecol and some of its analogs exert cytotoxic effect on cancer
cell lines suggesting that they may have potential as cancer chemopreventive agents.
However, it should be noted that some compounds such as polyphenols are known to be
poorly bioavailable, and extensively metabolized and converted by colonic microbiota into
other bioactive forms. Thus, the current study provides initial data to support the
antiproliferative potential of some quebecol derivatives.
In conclusion, we developed a simple and efficient method for the synthesis of quebecol and
its analogs. The method allowed the introduction of different functional groups in the three
aryl rings and gave good overall yield in five steps. The synthesized compounds were
evaluated for antiproliferative activity against a panel of cancer cell lines. Three analogs of
quebecol viz 8c, 8d and 8f showed slightly higher antiproliferative activity compared to
quebecol itself. The structure-activity relationship data provide insights for further
optimization of the quebecol scaffold in discovery of antiproliferative agents. Additional
studies are ongoing in our laboratory to determine the mechanism of action of this class of
compounds.
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Figure 1.
Structure of quebecol isolated from butanol extract of Canadian maple syrup.
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Figure 2.
Comparative antiproliferative activity of quebecol and its derivatives.
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Scheme 1.
Synthesis of quebecol and its derivatives. Reagents and conditions: i) n-BuLi, THF, -78 °C,
2 h; ii) CH3COBr, benzene, 25-30 °C, 5 h; iii) N,N-Diisopropylamine, n-BuLi, THF, -78 °C,
3 h; iv) LiAlH4, THF, 0 °C, 2 h; v) Pd/C, HCO2NH4, MeOH: EtOAc, 25-30 °C, 16 h.
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